Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Sep;44(3):456–459. doi: 10.1038/bjc.1981.205

Oestrogen-receptor status and sites of metastasis in breast cancer.

F C Campbell, R W Blamey, C W Elston, R I Nicholson, K Griffiths, J L Haybittle
PMCID: PMC2010785  PMID: 7284240

Abstract

The oestrogen receptor (RE) status of the primary tumour has been assessed in 466 of a consecutive series of 550 patients with primary operable breast cancer. All patients were followed up (without treatment) until the development of recurrence or metastases. Distant metastases have so far occurred in 124 patients and 82 have had symptomatic local or regional recurrence. A significant correlation exists between the RE status of the primary tumour and subsequent patterns of metastasis. Symptomatic metastases to regional lymph nodes are more common with RE- cancers. There is no significant difference in either time of onset or total incidence of distant metastases between patients with RE+ and RE- tumours. Distribution of distant metastases is influenced by RE status: RE+ tumours tend to recur in bone, RE- tumours show affinity for viscera.

Full text

PDF
456

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baum M. The management of advanced breast cancer. Br J Hosp Med. 1980 Jan;23(1):32, 35, 37-9. [PubMed] [Google Scholar]
  2. Bishop H. M., Blamey R. W., Elston C. W., Haybittle J. L., Nicholson R. I., Griffiths K. Relationship of oestrogen-receptor status to survival in breast cancer. Lancet. 1979 Aug 11;2(8137):283–284. doi: 10.1016/s0140-6736(79)90295-2. [DOI] [PubMed] [Google Scholar]
  3. Cutler S. J., Ardyce J. A., Taylor S. G., 3rd Classification of patients with disseminated cancer of the breast. Cancer. 1969 Nov;24(5):861–869. doi: 10.1002/1097-0142(196911)24:5<861::aid-cncr2820240502>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  4. Hähnel R., Woodings T., Vivian A. B. Prognostic value of estrogen receptors in primary breast cancer. Cancer. 1979 Aug;44(2):671–675. doi: 10.1002/1097-0142(197908)44:2<671::aid-cncr2820440238>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  5. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  6. Maynard P. V., Blamey R. W., Elston C. W., Haybittle J. L., Griffiths K. Estrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res. 1978 Nov;38(11 Pt 2):4292–4295. [PubMed] [Google Scholar]
  7. Meyer J. S., Rao B. R., Stevens S. C., White W. L. Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication. Cancer. 1977 Nov;40(5):2290–2298. doi: 10.1002/1097-0142(197711)40:5<2290::aid-cncr2820400541>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  8. Papaioannou A. N., Tanz F. J., Volk H. Fate of patients with recurrent carcinoma of the breast. Recurrence five or more years after initial treatment. Cancer. 1967 Mar;20(3):371–376. doi: 10.1002/1097-0142(1967)20:3<371::aid-cncr2820200305>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  9. Roberts M. M., Rubens R. D., King R. J., Hawkins R. A., Millis R. R., Hayward J. L., Forrest A. P. Oestrogen receptors and the response to endocrine therapy in advanced breast cancer. Br J Cancer. 1978 Sep;38(3):431–436. doi: 10.1038/bjc.1978.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. SHIMKIN M. B., LUCIA E. L., LOW-BEER V. A., BELL H. G. Recurrent cancer of the breast; analysis of frequency, distribution, and mortality at the University of California Hospital, 1918 to 1947, inclusive. Cancer. 1954 Jan;7(1):29–46. doi: 10.1002/1097-0142(195401)7:1<29::aid-cncr2820070105>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  11. Stewart J. F., King R. J., Sexton S. A., Millis R. R., Rubens R. D., Hayward J. L. Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Eur J Cancer. 1981 Apr;17(4):449–453. doi: 10.1016/0014-2964(81)90254-1. [DOI] [PubMed] [Google Scholar]
  12. TAYLOR S. G., 3rd Endocrine ablation in disseminated mammary carcinoma. Surg Gynecol Obstet. 1962 Oct;115:443–448. [PubMed] [Google Scholar]
  13. Walt A. J., Singhakowinta A., Brooks S. C., Cortez A. The surgical implications of estrophile protein estimations in carcinoma of the breast. Surgery. 1976 Oct;80(4):506–512. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES